CVE:KLH - Stellar Biotechnologies News Headlines

eye icon Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume5,576 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Stellar Biotechnologies (CVE KLH) News Headlines

Source:
DateHeadline
Stellar Biotechnologies Reports First Quarter Financial ResultsStellar Biotechnologies Reports First Quarter Financial Results
www.bizjournals.com - February 5 at 4:54 PM
Stellar Biotech up 11% on NIH contract for KLHStellar Biotech up 11% on NIH contract for KLH
seekingalpha.com - September 5 at 3:58 PM
Stellar Bio up 19% premarket on successful mid-stage study of therapeutic vaccine for lupusStellar Bio up 19% premarket on successful mid-stage study of therapeutic vaccine for lupus
seekingalpha.com - July 5 at 8:58 AM
Stellar Issues Statement on Favorable Clinical Study ResultsStellar Issues Statement on Favorable Clinical Study Results
finance.yahoo.com - July 5 at 8:58 AM
Stellar Biotechnologies Rockets Ahead on Research Study ResultsStellar Biotechnologies Rockets Ahead on Research Study Results
www.baystreet.ca - June 21 at 11:37 AM
Stellar Bio up 45% premarket bullish outlook for KLHStellar Bio up 45% premarket bullish outlook for KLH
seekingalpha.com - June 21 at 11:37 AM
Stellar Biotechnologies Announces Exercise of Warrants Resulting in Cash Proceeds of $3 MillionStellar Biotechnologies Announces Exercise of Warrants Resulting in Cash Proceeds of $3 Million
www.bizjournals.com - May 24 at 4:03 PM
Stellar up 23% premarket on robustness of protein manufacturing processStellar up 23% premarket on robustness of protein manufacturing process
seekingalpha.com - May 24 at 10:09 AM
Stellar Biotech Begins Scale-Up and Expansion Project at Port FacilityStellar Biotech Begins Scale-Up and Expansion Project at Port Facility
www.bizjournals.com - March 29 at 10:28 AM
Stellar Biotechnologies to Present at Marcum Investor Conference - PR Newswire (press release)Stellar Biotechnologies to Present at Marcum Investor Conference - PR Newswire (press release)
www.prnewswire.com - May 31 at 6:35 PM
Stellar Biotechnologies misses by $0.01, misses on revenueStellar Biotechnologies misses by $0.01, misses on revenue
seekingalpha.com - May 11 at 11:40 PM
BRIEF-STELLAR BIOTECHNOLOGIES Q2 LOSS PER SHARE $0.11BRIEF-STELLAR BIOTECHNOLOGIES Q2 LOSS PER SHARE $0.11
www.reuters.com - May 11 at 11:40 PM
Stellar Biotechnologies Reports Second Quarter 2017 Financial ResultsStellar Biotechnologies Reports Second Quarter 2017 Financial Results
www.bizjournals.com - May 9 at 5:55 PM
Stellar Biotechnologies Congratulates Partners Decision to Extend Drug Development for Diabetes - PR Newswire (press release)Stellar Biotechnologies Congratulates Partner's Decision to Extend Drug Development for Diabetes - PR Newswire (press release)
www.prnewswire.com - February 6 at 6:16 PM
Stellar Biotechnologies (SBOT) CEO Frank Oakes on Q4 2016 Results - Earnings Call Transcript - Seeking AlphaStellar Biotechnologies' (SBOT) CEO Frank Oakes on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - December 17 at 6:29 PM
Stellar Biotechnologies: Vaccine Tech Buoyed By PartnershipsStellar Biotechnologies: Vaccine Tech Buoyed By Partnerships
seekingalpha.com - June 23 at 11:47 AM
Neovacs and Stellar Biotechnologies sign joint venture agreement to create Neostell SAS - NasdaqNeovacs and Stellar Biotechnologies sign joint venture agreement to create Neostell SAS - Nasdaq
www.nasdaq.com - May 12 at 1:24 PM
BRIEF-Stellar Biotechnologies and Neovacs sign JV - ReutersBRIEF-Stellar Biotechnologies and Neovacs sign JV - Reuters
www.reuters.com - May 11 at 1:40 PM
Stellar Biotechnologies Gets a Positive SignStellar Biotechnologies Gets a Positive Sign
www.barrons.com - February 26 at 11:29 AM
Stellar Biotechnologies: Leveraging Demand For KLH In Rapidly Growing Immunotherapy MarketStellar Biotechnologies: Leveraging Demand For KLH In Rapidly Growing Immunotherapy Market
seekingalpha.com - February 5 at 11:04 AM
This page was last updated on 7/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel